Validation of critical process input parameters in the production of protein pharmaceutical products: a strategy for validating new processes or revalidating existing processes
PDA J Pharm Sci Technol
.
2000 Jul-Aug;54(4):315-9.
Authors
S Martin-Moe
1
,
J Ellis
,
M Coan
,
R Victor
,
J Savage
,
N Bogren
,
B Leng
,
C Lee
,
M Burnett
,
P Montgomery
Affiliation
1
Bayer Corporation, Berkeley, CA, USA.
PMID:
10969528
No abstract available
MeSH terms
Proteins*
Technology, Pharmaceutical*
Substances
Proteins